Fortescue (ASX:FMG) share price jumps as iron ore price soars

It's proving a good day on the ASX so far for one of the world's largest iron ore miners.

| More on:
Happy man in high vis vest and hard hat holds his arms up with fists clenched celebrating the rising Fortescue share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • The Fortescue share price is up 4% so far today
  • The iron ore price jumped more than 7% overnight
  • However, some brokers think Fortescue shares are too expensive

The Fortescue Metals Group Limited (ASX: FMG) share price is climbing almost 4% today amid a significant increase in the price of iron ore.

At the time of writing, Fortescue shares are swapping hands for $18.045 apiece, a gain of 3.71%.

Fortescue is one of the world's largest iron ore miners alongside BHP Group Ltd (ASX: BHP) and Rio Tinto Limited (ASX: RIO). Their share prices are up 1.08% and 1.71% respectively at the time of writing.

What happened to the iron ore price?

Fortescue generates its profit by mining and selling iron ore. An increase in the iron ore price can be a boost to Fortescue's net profit after tax (NPAT).

In overnight markets, the spot iron ore price increased by 7.3% to US$145.45 per tonne. In dollar terms, it was an increase of US$9.90 per tonne.

The iron ore price has continued to be volatile amid the Russian invasion of Ukraine and China locking down certain areas of the country to try to control the spread of COVID-19.

Which way is the iron ore price expected to go next?

Commodity prices are challenging to predict. But some analysts have a go.

China is a significant buyer of a lot of Australia's iron, so a slowdown of purchasing can have a sizeable impact on the iron ore price.

The broker Citi recently said the iron ore price could drop to US$70 per tonne in the long-term, though this was an upgrade from the expectation of US$60 per tonne.

In the next couple of years, Citi thinks the iron ore price may reduce to US$80 per tonne. But Citi admitted it's possible it could be higher than that.

Other brokers, such as UBS, also have estimated the iron ore price will drop in the coming years.

Is the Fortescue share price an opportunity?

A lot of brokers believe the Fortescue share price is overvalued. Citi, UBS, and Morgan Stanley all think the business is a 'sell'.

Morgan Stanley has a particularly negative outlook for the Fortescue share price, with a price target of $13. That implies a possible decline of close to 30% over the next year.

Citi has a price target of $16 on the business, suggesting a drop of around 11%.

Brokers think Fortescue looks expensive compared to peers such as BHP and Rio Tinto. The discount applied to Fortescue's lower grade iron ore has increased compared to the middle of 2021.

Some analysts, such as Credit Suisse, also want more information and disclosure about Fortescue Future Industries (FFI).

FFI continues to make progress

Fortescue wants FFI to become one of the world leaders of green hydrogen production with a global portfolio of projects. FFI's goal is to produce 15 million tonnes of green hydrogen per year by 2030 for the global market.

It has hired some high-profile individuals to drive the business forward.

The latest appointment is the Reserve Bank of Australia Deputy Governor Dr Guy Debelle who will become FFI's chief financial officer (CFO).

Fortescue said Dr Debelle will help facilitate the green energy goals, while also delivering value for shareholders and economic benefits for the communities where FFI operates.

In terms of decarbonisation, one of the latest developments from Fortescue is the partnership with Airbus to create a plane by 2035 that runs on green hydrogen.

Fortescue share price snapshot

The Fortescue share price is swimming in a sea of red over all recent timelines.

It is down 11.5% over the past year, 6% this year to date, almost 15% over the past month, and 4% over the past week.

Motley Fool contributor Tristan Harrison owns Fortescue Metals Group Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

Winning woman smiles and holds big cup while losing woman looks unhappy with small cup
Share Gainers

Here are the top 10 ASX 200 shares today

It was a dour Tuesday for ASX investors.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why Brightstar Resources, Immutep, Pilbara Minerals, and Race Oncology shares are roaring higher

These shares are having a strong session on Tuesday. But why?

Read more »

A graphic of a pink rocket taking off above an increasing chart.
Healthcare Shares

Guess which ASX 300 healthcare share is rocketing 28% on global expansion news

Investors are piling into the ASX 300 healthcare share on Tuesday. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a Garfield kind of Monday for investors.

Read more »

Happy shareholders clap and smile as they listen to a company earnings report.
Share Gainers

Why Artrya, Clinuvel, Imugene, and Pilbara Minerals shares are storming higher today

These shares are starting the week in a positive fashion. But why?

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Share Gainers

4 ASX 200 stocks smashing the benchmark this week

Investors have been piling into these four ASX 200 stocks this week. Let’s see why.

Read more »